Quiet on the insider front: nobody at ESSA Pharma Inc. bought or sold EPIX shares at market prices this past year.
Looking at the quarterly pattern: No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Aug 7, 2025 | BVF INC/IL | 10% Owner | Sell | 79 | $1.88 | $149 | SEC |
| Aug 7, 2025 | BVF INC/IL | 10% Owner | Sell | 11 | $1.88 | $21 | SEC |
| Aug 7, 2025 | BVF INC/IL | 10% Owner | Sell | 66 | $1.88 | $124 | SEC |
| Nov 5, 2024 | BB BIOTECH AG | 10% Owner | Sell | 2,000,000 | $1.53 | $3.1M | SEC |
| Nov 5, 2024 | BB BIOTECH AG | 10% Owner | Sell | 2,000,000 | $1.53 | $3.1M | SEC |
| Nov 5, 2024 | BB BIOTECH AG | 10% Owner | Sell | 1,879,583 | $1.51 | $2.8M | SEC |
| Nov 5, 2024 | BB BIOTECH AG | 10% Owner | Sell | 2,000,000 | $1.53 | $3.1M | SEC |
| Oct 7, 2024 | Virsik Peter | COO | Sell | 694 | $6.03 | $4K | SEC |
| Sep 9, 2024 | Virsik Peter | COO | Sell | 694 | $6.00 | $4K | SEC |
| Sep 3, 2024 | Virsik Peter | COO | Sell | 2,082 | $6.03 | $13K | SEC |
| May 6, 2024 | Virsik Peter | COO | Sell | 694 | $6.95 | $5K | SEC |
| Apr 5, 2024 | Virsik Peter | COO | Sell | 694 | $7.94 | $6K | SEC |
| Mar 5, 2024 | Virsik Peter | COO | Sell | 694 | $8.98 | $6K | SEC |
| Feb 7, 2024 | Virsik Peter | COO | Sell | 72,782 | $10.29 | $749K | SEC |
| Feb 6, 2024 | Virsik Peter | COO | Sell | 500 | $10.04 | $5K | SEC |
There were no open-market insider trades in EPIX in the last 12 months. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
No congressional trades in EPIX were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).